OnDemand - Visiting Professor - April 2023 - Featuring Prem Subramanian, MD, PhD [Non-CME]

Visiting Professor Lecture - April 2023 - Recorded on April 19, 2023

Featuring Prem Subramanian, MD, PhD

Prem S. Subramanian, MD, PhD, is the Clifford R. and Janice N. Merrill Endowed Chair in Ophthalmology and is professor of ophthalmology, neurology, and neurosurgery and vice chair for academic affairs at the Sue Anschutz-Rodgers University of Colorado Eye Center/School of Medicine. He is also Adjunct Professor of Surgery at the Uniformed Services University of the Health Sciences.

He received his MD with high honors and PhD in molecular and human genetics at Baylor College of Medicine in Houston, Texas. He is a founding member of the medical staff of the Marcus Institute for Brain Health, which serves to improve the functioning of patients with traumatic brain injury through intensive outpatient rehabilitation. He is also an active orbitocranial surgeon with a specific interest in tumors of the skull base and small-incisional approaches. His current research is focused on finding more effective medical treatments for patients at risk for progressive thyroid ophthalmopathy, developing better treatments of vision problems in patients with increased intracranial pressure, and using vestibular and visual therapies to overcome visual and balance dysfunction after traumatic brain injury.

He is President of the North American Neuro-Ophthalmology Society, Vice Chair of the Council of the American Academy of Ophthalmology and member of the AAO Board of Trustees and serves on the Board of Directors of the North American Society of Academic Orbital Surgeons; in addition, he has published over 240 research articles, book chapters, and web-based educational materials and is a dedicated educator in several countries around the world.

Mitigation of Relevant Financial Relationships

In compliance with the Standards for Integrity and Independence in Accredited Continuing Education set by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Wills Eye Hospital that the information presented at CME activities will be commercially unbiased and based upon clinical and scientific evidence. To help participants make judgments about the presence of commercial bias, Wills Eye Hospital provides information that all individuals in a position to control the content of a CME activity (including faculty, planners, reviewers or others) have disclosed about all financial relationships they have with ineligible companies. All relevant financial relationships have been mitigated.

Ineligible companies are companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company. The CME activity staff at Wills Eye Hospital report no financial relationships with ineligible companies.